1 year return (CAGR)
208.77%
Purple Biotech Exchange (NASDAQ, USD)
PPBT
1.76
+0.04 (+2.33%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-58.03%
5 year return (CAGR)
-55.55%
10 year return (CAGR)
-29.64%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.86M
Price/Sales
-
Ent value
-419.71K
Price/Book
0.23
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
196.56%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.70 |
| Daily high | 1.83 |
| Daily low | 1.68 |
| Daily Volume | 56K |
| All-time high | 139.80 |
| 1y analyst estimate | 17.00 |
| Beta | -0.54 |
| EPS (TTM) | -2.26 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| PPBT | S&P500 | |
| Current price drop from All-time high | -98.74% | -2.19% |
| Highest price drop | -99.60% | -56.47% |
| Date of highest drop | 10 Sep 2025 | 9 Mar 2009 |
| Avg drop from high | -71.23% | -10.68% |
| Avg time to new high | 113 days | 12 days |
| Max time to new high | 1406 days | 1805 days |
News
